Description of a healthy lifestyle intervention for people with serious mental illness taking second-generation antipsychotics

Int J Ment Health Nurs. 2011 Dec;20(6):428-37. doi: 10.1111/j.1447-0349.2011.00747.x. Epub 2011 May 12.

Abstract

Weight gain and obesity has reached epidemic proportions, with the prevalence of metabolic syndrome (MetS) reaching 20-25% of the global population. MetS is a cluster of metabolic abnormalities, including weight gain, associated with an increased risk of cardiovascular disease, diabetes, and stroke. While individuals in the general population are at risk of physical conditions, such as MetS, people with mental illness are at even higher risk. The increased incidence of MetS for people with serious mental illness has been linked to the use of second-generation antipsychotic medication. This paper describes the content, structure, and development of 'Passport 4 Life', a healthy lifestyle intervention to maintain weight and prevent further weight gain for people with serious mental illness. While there are a number of diet and lifestyle programmes available for the general population, Passport 4 Life was specifically designed as an intervention to address the needs of people with serious mental illness taking second-generation antipsychotics. Passport 4 Life comprises 12 weekly group sessions that include the concepts and spirit of motivational interviewing, nutrition, and exercise education, combined with weekly exercise activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Exercise
  • Feeding Behavior
  • Humans
  • Mental Disorders / drug therapy*
  • Mental Disorders / psychology
  • Metabolic Syndrome / chemically induced
  • Metabolic Syndrome / prevention & control
  • Obesity / chemically induced
  • Obesity / prevention & control
  • Patient Education as Topic / methods
  • Psychiatric Nursing / methods
  • Risk Reduction Behavior*
  • Weight Gain / drug effects

Substances

  • Antipsychotic Agents